321 related articles for article (PubMed ID: 11893808)
1. Nosocomial spread of linezolid-resistant, vancomycin-resistant Enterococcus faecium.
Herrero IA; Issa NC; Patel R
N Engl J Med; 2002 Mar; 346(11):867-9. PubMed ID: 11893808
[No Abstract] [Full Text] [Related]
2. Emergence of linezolid resistance in the vancomycin-resistant Enterococcus faecium multilocus sequence typing C1 epidemic lineage.
Bonora MG; Solbiati M; Stepan E; Zorzi A; Luzzani A; Catania MR; Fontana R
J Clin Microbiol; 2006 Mar; 44(3):1153-5. PubMed ID: 16517918
[TBL] [Abstract][Full Text] [Related]
3. Nosocomial spread of Enterococcus faecium resistant to vancomycin and linezolid in a tertiary care medical center.
Dobbs TE; Patel M; Waites KB; Moser SA; Stamm AM; Hoesley CJ
J Clin Microbiol; 2006 Sep; 44(9):3368-70. PubMed ID: 16954275
[TBL] [Abstract][Full Text] [Related]
4. Linezolid-resistant, vancomycin-resistant Enterococcus faecium infection in patients without prior exposure to linezolid.
Rahim S; Pillai SK; Gold HS; Venkataraman L; Inglima K; Press RA
Clin Infect Dis; 2003 Jun; 36(11):E146-8. PubMed ID: 12766857
[TBL] [Abstract][Full Text] [Related]
5. First report of a linezolid- and vancomycin-resistant Enterococcus faecium strain in Korea.
Bae HG; Sung H; Kim MN; Lee EJ; Koo Lee S
Scand J Infect Dis; 2006; 38(5):383-6. PubMed ID: 16709544
[TBL] [Abstract][Full Text] [Related]
6. Rapid emergence of resistance to linezolid during linezolid therapy of an Enterococcus faecium infection.
Seedat J; Zick G; Klare I; Konstabel C; Weiler N; Sahly H
Antimicrob Agents Chemother; 2006 Dec; 50(12):4217-9. PubMed ID: 16982791
[TBL] [Abstract][Full Text] [Related]
7. Linezolid treatment for osteomyelitis due to vancomycin-resistant Enterococcus faecium.
Till M; Wixson RL; Pertel PE
Clin Infect Dis; 2002 May; 34(10):1412-4. PubMed ID: 11981739
[TBL] [Abstract][Full Text] [Related]
8. Varying linezolid susceptibility of vancomycin-resistant Enterococcus faecium isolates during therapy: a case report.
Swoboda S; Fritz S; Martignoni ME; Feldhues RA; Hoppe-Tichy T; Buchler MW; Geiss HK
J Antimicrob Chemother; 2005 Oct; 56(4):787-9. PubMed ID: 16143710
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of fosfomycin tromethamine and linezolid against vancomycin-resistant Enterococcus faecium isolates.
Cilli F; Pullukcu H; Aydemir S; Sipahi OR; Tasbakan M; Turhan A; Ulusoy S
Int J Antimicrob Agents; 2008 Mar; 31(3):297-8. PubMed ID: 18180144
[No Abstract] [Full Text] [Related]
10. Emerging linezolid-resistant Enterococcus faecalis and Enterococcus faecium isolated from two Austrian patients in the same intensive care unit.
Johnson AP; Tysall L; Stockdale MV; Woodford N; Kaufmann ME; Warner M; Livermore DM; Asboth F; Allerberger FJ
Eur J Clin Microbiol Infect Dis; 2002 Oct; 21(10):751-4. PubMed ID: 12415476
[TBL] [Abstract][Full Text] [Related]
11. Vancomycin-resistant Enterococcus faecium meningitis successfully managed with linezolid: case report and review of the literature.
Zeana C; Kubin CJ; Della-Latta P; Hammer SM
Clin Infect Dis; 2001 Aug; 33(4):477-82. PubMed ID: 11462183
[TBL] [Abstract][Full Text] [Related]
12. Intensive care unit dissemination of multiple clones of linezolid-resistant Enterococcus faecalis and Enterococcus faecium.
Ntokou E; Stathopoulos C; Kristo I; Dimitroulia E; Labrou M; Vasdeki A; Makris D; Zakynthinos E; Tsakris A; Pournaras S
J Antimicrob Chemother; 2012 Aug; 67(8):1819-23. PubMed ID: 22532462
[TBL] [Abstract][Full Text] [Related]
13. Increasing incidence of linezolid-intermediate or -resistant, vancomycin-resistant Enterococcus faecium strains parallels increasing linezolid consumption.
Scheetz MH; Knechtel SA; Malczynski M; Postelnick MJ; Qi C
Antimicrob Agents Chemother; 2008 Jun; 52(6):2256-9. PubMed ID: 18391028
[TBL] [Abstract][Full Text] [Related]
14. In vitro activities of tigecycline, daptomycin, linezolid and quinupristin/dalfopristin against glycopeptide-resistant Enterococcus faecium.
Abb J
Int J Antimicrob Agents; 2007 Mar; 29(3):358-60. PubMed ID: 17229553
[No Abstract] [Full Text] [Related]
15. Risk factors associated with the development of infection with linezolid- and vancomycin-resistant Enterococcus faecium.
Pai MP; Rodvold KA; Schreckenberger PC; Gonzales RD; Petrolatti JM; Quinn JP
Clin Infect Dis; 2002 Nov; 35(10):1269-72. PubMed ID: 12410489
[TBL] [Abstract][Full Text] [Related]
16. Successful treatment of vancomycin-resistant Enterococcus endocarditis with oral linezolid.
Babcock HM; Ritchie DJ; Christiansen E; Starlin R; Little R; Stanley S
Clin Infect Dis; 2001 May; 32(9):1373-5. PubMed ID: 11303275
[TBL] [Abstract][Full Text] [Related]
17. Intra-hospital dissemination of quinupristin/dalfopristin- and vancomycin-resistant Enterococcus faecium in a paediatric ward of a German hospital.
Werner G; Klare I; Spencker FB; Witte W
J Antimicrob Chemother; 2003 Jul; 52(1):113-5. PubMed ID: 12805253
[TBL] [Abstract][Full Text] [Related]
18. First linezolid- and vancomycin-resistant Enterococcus faecium strain in Taiwan.
Liao CH; Tseng SP; Fang CT; Teng LJ; Hsueh PR
J Antimicrob Chemother; 2005 Apr; 55(4):598-9. PubMed ID: 15728149
[No Abstract] [Full Text] [Related]
19. Delayed discovery of linezolid-resistant, vancomycin-resistant Enterococcus faecium: lessons learned.
Schwartz MD; Shive DK; Shaikh ZH
Clin Infect Dis; 2004 Jan; 38(1):155-6. PubMed ID: 14679466
[No Abstract] [Full Text] [Related]
20. [Linezolid for the treatment of newborns infected with vancomycin-resistant Enterococcus faecium].
Berberian G; Castro G; Fistolera S; Travaglianti M; Lopardo H; Mastroianni A; Rosanova MT
Rev Argent Microbiol; 2009; 41(1):34-8. PubMed ID: 19391524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]